HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells

INTRODUCTION: Amplification of the HER-2 receptor tyrosine kinase has been implicated in the pathogenesis and aggressive behavior of approximately 25% of invasive human breast cancers. Clinical and experimental evidence suggest that aberrant HER-2 signaling contributes to tumor initiation and diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Cindy A, Cajulis, Elaina E, Green, Jennifer L, Olsen, Taylor M, Chung, Young Ah, Damore, Michael A, Dering, Judy, Calzone, Frank J, Slamon, Dennis J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410754/
https://www.ncbi.nlm.nih.gov/pubmed/16457687
http://dx.doi.org/10.1186/bcr1343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410754/
https://www.ncbi.nlm.nih.gov/pubmed/16457687
http://dx.doi.org/10.1186/bcr1343

Ejemplares similares